Literature DB >> 18398934

Mast cell-mediated immune responses through IgE antibody and Toll-like receptor 4 by malarial peroxiredoxin.

Takahisa Furuta1, Shinobu Imajo-Ohmi, Hiroyuki Fukuda, Shigeyuki Kano, Kensuke Miyake, Naohiro Watanabe.   

Abstract

In this study, 2-Cys Plasmodium berghei ANKA (PbA) peroxiredoxin (Prx) was identified as an antigenic protein recognized by an anti-PbA IgE antibody using two-dimensional polyacrylamide gel electrophoresis and proteomic analysis. Innate immune responses to PbAPrx were examined using cells from mice deficient in Toll-like receptors (TLR) or related molecules, and it was demonstrated that responses were severely impaired in TLR4(-/-), MyD88(-/-) and MD-2(-/-) mice, but not in Toll/IL-1 receptor domain-containing adaptor inducing IFN-gamma (TRIF)(-/-), TLR2(-/-) or radioprotective 105 (RP105)(-/-) mice. An association between PbAPrx and TLR4 was observed following immunoprecipitation and immunoblotting, suggesting that PbAPrx was associated with TLR4/MD-2. Interactions between Prx and TLR4/MD-2 were also examined by flow cytometry using TLR4/MD-2- or TLR2-expressing cells. NFkappaB/GFP activity was observed in TLR4/MD-2- but not in TLR2-expressing cells following stimulation with Prx. However, this effect was not observed after treatment with proteinase K, suggesting that PbAPrx is a protein ligand for TLR4 and that the PbAPrx activity observed in this study is not due to contamination with LPS. These findings indicate that malarial Prx induces IgE-mediated protection through FcepsilonRI on mast cells and innate immunity through TLR4 with MyD88 and MD-2, suggesting a novel function for malarial Prx in innate and acquired immune responses in malaria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18398934     DOI: 10.1002/eji.200738059

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  31 in total

1.  Macrophage migration inhibitory factor: a downregulator of early T cell-dependent IFN-gamma responses in Plasmodium chabaudi adami (556 KA)-infected mice.

Authors:  Diane Tshikudi Malu; Benoit Bélanger; François Desautels; Karine Kelendji; Esther Dalko; Jaime Sanchez-Dardon; Lin Leng; Richard Bucala; Abhay R Satoskar; Tatiana Scorza
Journal:  J Immunol       Date:  2011-04-25       Impact factor: 5.422

2.  Divergent roles of IRAK4-mediated innate immune responses in two experimental models of severe malaria.

Authors:  Constance A M Finney; Ziyue Lu; Michael Hawkes; Wen-Chen Yeh; W Conrad Liles; Kevin C Kain
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

3.  Adipocyte-derived PAMM suppresses macrophage inflammation by inhibiting MAPK signalling.

Authors:  Fang Guo; Hui He; Zhi-Chao Fu; Shengping Huang; Tingtao Chen; Christopher J Papasian; Leslie R Morse; Yan Xu; Ricardo A Battaglino; Xiao-Feng Yang; Zhisheng Jiang; Hong-Bo Xin; Mingui Fu
Journal:  Biochem J       Date:  2015-10-05       Impact factor: 3.857

4.  Evaluation of the immune response against Trypanosoma cruzi cytosolic tryparedoxin peroxidase in human natural infection.

Authors:  Magalí C Girard; Gonzalo R Acevedo; Lucía López; Micaela S Ossowski; María D Piñeyro; Juan P Grosso; Marisa Fernandez; Yolanda Hernández Vasquez; Carlos Robello; Karina A Gómez
Journal:  Immunology       Date:  2018-08-03       Impact factor: 7.397

5.  Peroxiredoxin 1 stimulates secretion of proinflammatory cytokines by binding to TLR4.

Authors:  Jonah R Riddell; Xiang-Yang Wang; Hans Minderman; Sandra O Gollnick
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

6.  Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy.

Authors:  Wolfgang W Leitner; Elke S Bergmann-Leitner; Evelina Angov
Journal:  Malar J       Date:  2010-05-27       Impact factor: 2.979

Review 7.  Fc-receptors and immunity to malaria: from models to vaccines.

Authors:  R J Pleass
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

8.  CD36 and TLR interactions in inflammation and phagocytosis: implications for malaria.

Authors:  Laura K Erdman; Gabriela Cosio; Andrew J Helmers; D Channe Gowda; Sergio Grinstein; Kevin C Kain
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

9.  Elevated levels of vascular endothelial growth factor (VEGF) and soluble vascular endothelial growth factor receptor (VEGFR)-2 in human malaria.

Authors:  Takahisa Furuta; Mikio Kimura; Naohiro Watanabe
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

Review 10.  Mast Cell-Targeted Strategies in Cancer Therapy.

Authors:  Michele Ammendola; Rosario Sacco; Giuseppe Sammarco; Maria Luposella; Rosa Patruno; Cosmo Damiano Gadaleta; Giovambattista De Sarro; Girolamo Ranieri
Journal:  Transfus Med Hemother       Date:  2016-03-09       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.